271 related articles for article (PubMed ID: 22384081)
1. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.
Pourreyron C; Reilly L; Proby C; Panteleyev A; Fleming C; McLean K; South AP; Foerster J
PLoS One; 2012; 7(2):e31827. PubMed ID: 22384081
[TBL] [Abstract][Full Text] [Related]
2. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
[TBL] [Abstract][Full Text] [Related]
3. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
4. Evidence for altered Wnt signaling in psoriatic skin.
Gudjonsson JE; Johnston A; Stoll SW; Riblett MB; Xing X; Kochkodan JJ; Ding J; Nair RP; Aphale A; Voorhees JJ; Elder JT
J Invest Dermatol; 2010 Jul; 130(7):1849-59. PubMed ID: 20376066
[TBL] [Abstract][Full Text] [Related]
5. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
7. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinoma.
Bartis D; Csongei V; Weich A; Kiss E; Barko S; Kovacs T; Avdicevic M; D'Souza VK; Rapp J; Kvell K; Jakab L; Nyitrai M; Molnar TF; Thickett DR; Laszlo T; Pongracz JE
PLoS One; 2013; 8(3):e57393. PubMed ID: 23505429
[TBL] [Abstract][Full Text] [Related]
9. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
Mikels AJ; Nusse R
PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
[TBL] [Abstract][Full Text] [Related]
10. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a attenuates Wnt/β-catenin signalling in human dermal papilla cells.
Kwack MH; Kim MK; Kim JC; Sung YK
Exp Dermatol; 2013 Mar; 22(3):229-31. PubMed ID: 23489428
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
Zhang Y; Tu C; Zhang D; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
Cell Physiol Biochem; 2015; 36(5):1890-902. PubMed ID: 26202350
[TBL] [Abstract][Full Text] [Related]
14. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
15. Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon.
Romanowska M; Evans A; Kellock D; Bray SE; McLean K; Donandt S; Foerster J
PLoS One; 2009; 4(4):e5354. PubMed ID: 19399181
[TBL] [Abstract][Full Text] [Related]
16. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
17. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
[TBL] [Abstract][Full Text] [Related]
18. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.
Ekström EJ; Sherwood V; Andersson T
PLoS One; 2011 Apr; 6(4):e18674. PubMed ID: 21494614
[TBL] [Abstract][Full Text] [Related]
19. Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration.
Cheng CW; Yeh JC; Fan TP; Smith SK; Charnock-Jones DS
Biochem Biophys Res Commun; 2008 Jan; 365(2):285-90. PubMed ID: 17986384
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A
Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]